JOSEPH BURNETT - 17 Feb 2026 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role
CEO and President, Director
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett
Issuer symbol
CLPT
Transactions as of
17 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 16:07:33 UTC
Previous filing
27 Jan 2026
Next filing
26 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BURNETT JOSEPH CEO and President, Director C/O CLEARPOINT NEURO, INC., 120 S. SIERRA AVE., SUITE 100, SOLANA BEACH /s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett 19 Feb 2026 0001721010

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLPT Restricted Stock Units Award $0 +147,275 $0.000000 147,275 17 Feb 2026 Common Stock 147,275 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
F2 The restricted stock units vest as follows: (i) 20% of the total shares on February 17, 2027; (ii) 40% of the total shares on February 17, 2028; and (iii) 40% of the total shares on February 17, 2029.